Medtronic

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Medtronic 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MDT

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. 

CEO
Geoffrey Straub Martha
CEOGeoffrey Straub Martha
Employees
95,000
Employees95,000
Headquarters
Galway, Galway
HeadquartersGalway, Galway
Founded
2014
Founded2014
Employees
95,000
Employees95,000

MDT Key Statistics

Market cap
114.05B
Market cap114.05B
Price-Earnings ratio
22.35
Price-Earnings ratio22.35
Dividend yield
3.14%
Dividend yield3.14%
Average volume
9.29M
Average volume9.29M
High today
$91.20
High today$91.20
Low today
$89.10
Low today$89.10
Open price
$90.52
Open price$90.52
Volume
5.16M
Volume5.16M
52 Week high
$106.33
52 Week high$106.33
52 Week low
$73.31
52 Week low$73.31

Stock Snapshot

With a market cap of 114.05B, Medtronic(MDT) trades at $89.16. The stock has a price-to-earnings ratio of 22.35 and currently yields dividends of 3.14%.

On 2026-09-23, Medtronic(MDT) stock moved within a range of $89.10 to $91.20. With shares now at $89.16, the stock is trading +0.1% above its intraday low and -2.2% below the session's peak.

Trading activity shows a volume of 5.16M, compared to an average daily volume of 9.29M.

The stock's 52-week range extends from a low of $73.31 to a high of $106.33.

The stock's 52-week range extends from a low of $73.31 to a high of $106.33.

MDT News

Nasdaq 24h
Jim Cramer Called Medtronic a "Quandary." Here's Why He's Exactly Right.

Key Points Over time, Medtronic's business got bloated, and growth slowed. The medical device giant overhauled its business and is starting to see stronger re...

Jim Cramer Called Medtronic a "Quandary." Here's Why He's Exactly Right.
Simply Wall St 5d
What Is Drawing Fresh Attention To Medtronic?

Medtronic (MDT) just secured FDA clearance for its LigaSure RAS Maryland jaw device on the Hugo robotic-assisted surgery system. This technical update gives inv...

What Is Drawing Fresh Attention To Medtronic?
TipRanks 6d
Medtronic Advances Diabetes Spin-Off with Share Exchange

Medtronic ( (MDT) ) has issued an announcement. On September 14, 2026, Medtronic launched an exchange offer for up to 225,361,295 newly issued shares of MiniMe...

Analyst ratings

66%

of 29 ratings
Buy
65.5%
Hold
34.5%
Sell
0%

More MDT News

The Motley Fool 6d
Should You Buy Medtronic Stock as Its Hugo Surgical Robot Gains Ground?

Shares of Medtronic (MDT +0.65%) are down more than 3% this year, presenting a compelling opportunity for savvy, growth-oriented investors. The healthcare compa...

Should You Buy Medtronic Stock as Its Hugo Surgical Robot Gains Ground?
TipRanks 6d
Medtronic Reaffirmed at Buy as $700M Cornerstone Robotics Deal Strengthens Surgical Portfolio; Price Target Unchanged at $114

Medtronic, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael Matson from Needham maintained a Buy rating on the stock...

People also own

Based on the portfolios of people who own MDT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.